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Introduction
In 2007, approximately 56 million units of blood
were collected in developed countries. In these
countries (~25% of the world's population), the
common risks associated with blood transfusions are
minimised by careful screening of donors, extensive
testing of units for infectious agents and routine cross-
matching. Well-developed logistics enable the level
of wastage due to outdating of stored units to be kept
low.
Recent clinical studies demonstrating a negative
correlation between RBC transfusions and clinical
outcomes have led to a significant attention being
focused on the quality and efficacy of stored blood
used in transfusion therapy1-16.
In RBC separated from whole blood and stored in
a refrigerator away from the turbulent environment
of circulation, the normal senescence processes are
suspended. When stored RBC are returned to the
circulation, a normal life-span is observed but only
for cells not removed by the reticuloendothelial system
of the recipient shortly after reinfusion17. After 6 weeks
of storage, up to 25% of stored cells are removed
within 24 hours of infusion due to the damage inflicted
on the RBC during their collection, component
preparation and refrigerated storage. This damage
("storage lesion") manifests as changes in biochemical
and physical parameters of RBC as well as in-storage
haemolysis and reduced post-transfusion 24-hour
recovery in vivo.
The clearance of damaged RBC reduces the
therapeutic efficacy of the unit, stresses the
reticuloendothelial system of the recipient and adds
an excess iron burden to chronically transfused
patients. Moreover, transfusion of damaged RBC is
suspected as a possible cause of clinically observed
complications of transfusion therapy. Current
controversy surrounding the possible causal
relationship between the "age" of units and negative
outcomes in patients receiving transfusions13,15,16,18-41
stems from the fact the most of the storage-related
damages increase with storage duration.
In the past, various strategies were suggested and
tested to reduce the rate of development of storage
lesions. These strategies can be classified into four
categories: (i) manipulation of pH; (ii)
supplementation of metabolic precursors; (iii)
manipulation of osmotic balance and increase of the
volume of the suspending medium; and (iv) reduction
of oxidative stress by adding protective molecules.
Several studies employing a combination of these
strategies have reported maintenance of viability
allowing an extension of storage beyond the current
limit of 6 weeks42-47.
Our approach to improving the quality and efficacy
of stored RBC has been focused on reducing oxidative
damage by removing oxygen at the beginning of
storage and maintaining the anaerobic state throughout
the storage period48-52.
In this article, the mechanisms of oxidative
damage, its involvement in the development of storage
lesion, as well as various attempts to reduce such
damage are summarised. Emphasis is placed on
reviewing results of a series of preliminary clinical
studies conducted by our group to investigate the
effect of anaerobic storage to reduce such damage by
storing RBC under oxygen-depleted conditions.
Red blood cell storage lesions
and their effect on erythrocyte function
Physiological function of red blood cells
One of the primary functions of RBC is to transport
oxygen (O2) from the lungs to metabolising tissues:
O2 diffuses from the alveoli into the pulmonary
capillaries, binds to haemoglobin (Hb) in RBC and
dissolves in plasma, and is then transported with the
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flow of blood to the microvascular networks where it
is released from Hb, diffuses across the walls of
capillaries, pre-capillary arterioles and post-capillary
venules to the cells of tissues53-57. To maintain adequate
perfusion of microvascular networks, RBC must be
able to continually deform at physiologically high
haematocrits, under a wide range of flow conditions,
in vessels with diameters ranging from 3-8 µm
(capillaries) to 50-100 µm (arterioles and venules).
Maintaining an appropriate level of "deformability"
is, therefore, crucial for RBC physiological
function58,59.
In addition to transporting O2, RBC can sense the
state of local tissue oxygenation and adjust the rate of
O2 delivery by regulating the local blood flow in
microvascular networks60-62 via three possible nitric
oxide (NO)-mediated mechanisms: (i) release of
adenosine triphosphate (ATP) to stimulate production
of NO by the endothelial cells lining the walls of the
vessels63-68; (ii) release of NO from S-nitroso- (SNO)
Hb upon deoxygenation of Hb69-72; and (iii) reduction
of nitrite (NO2–) present in the blood stream to NO by
deoxyhaemoglobin73-75. Vessels dilate in response to
the release of NO, thus changing their fluidic
resistance and consequently the rate of blood flow.
The effect of storage on red blood cell functions
In 4°C liquid storage, the biochemical and
mechanical properties of RBC deteriorate
progressively. These "storage lesions" affect all of the
key RBC functions15,36,71,76.
Loss of viability
RBC stored for a period of time at 4°C lose
viability. Some may undergo spontaneous haemolysis
while in storage; others lose the ability to survive in
the recipient's circulation following transfusion. The
survival of transfused RBC is usually measured by
infusing subjects with a sample of stored RBC tagged
with a radioactive label (51Cr), and then sampling the
blood of the recipient periodically to determine the
kinetics of RBC clearance51,77-79.  A sizable portion of
transfused RBC is cleared from the circulation of the
recipient in the first 24 hours after transfusion, and
the number of these non-viable RBC increases with
duration of storage. Transfused RBC that still remain
in circulation after this initial period of rapid clearance
will have relatively normal life-spans. Currently, the
US Food and Drug Administration requires that stored
RBC experience less than 1% in-storage haemolysis
and that at least 75% of stored RBC survive in the
recipient 24 hours after transfusion80,81.
Biochemical changes
Adenosine triphosphate
When RBC are stored in additive solutions, the
concentration of ATP remains level or even increases
early in storage, peaks at about 2 weeks, but then
gradually declines to below 50% by week 6 of
storage82-84.  Anaerobic oxidation of glucose (i.e.,
glycolysis) is the only source of energy for RBC.  The
initial steps of this process require ATP; it cannot
continue when ATP becomes depleted. The fall of ATP
levels and of the total adenylate content
(ATP+ADP+AMP) is associated with poor in vivo
survival85. The loss of ATP may also diminish the
ability of transfused RBC to effect NO-mediated
arteriole vasodilatation in response to hypoxia64,86,87.
2,3-diphosphoglycerate
The 2,3-diphosphoglycerate (2,3-DPG) levels
decline rapidly over the first week of storage, falling
to undetectable levels by the end of week 215,71,83,84.
Because of the loss of 2,3-DPG, stored RBC release
O2 to the tissues less readily than normal cells.  After
transfusion, however, 2,3-DPG is rapidly re-
synthesised to 50% of the normal level in as little as 7
hours, and to 95% of the normal level in 2-3 days36,88-
91
.This restoration of 2,3-DPG returns the Hb-O2
dissociation curve of stored RBC back to its normal
position, and thus normalises the amount of O2
functionally available to tissues.
S-nitroso haemoglobin
SNO-Hb is lost precipitously in the first few hours
of storage, which may affect the ability of RBC to
regulate the local blood flow in response to low
pO271,92.  SNO-Hb, however, recovers within several
hours in the body15. Also, it may be not essential for
the RBC-dependent hypoxic vasodilatation72.
Changes in mechanical properties
During storage, some RBC change shape from
deformable biconcave disks to echinocytes to sphero-
echinocytes36,93. The number of the irreversibly
deformed spherocytes in the population of stored RBC
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gradually increases throughout the duration of
storage93. The significantly reduced surface area-to-
volume ratio of spherocytes limits their ability to pass
through the smallest capillaries94; spherocytes are
quickly culled from circulation by the body of the
recipient84,95.
RBC gradually lose their "deformability" during
storage – specifically, the ability to undergo folding
deformations (the kind 8-µm RBC need to be able to
do to traverse 3-7 µm capillaries)83,93,96-100, and shear
deformations (the kind RBC will experience in larger
vessels, arterioles and venules)101-106.Because of this
storage-induced degradation of their mechanical
properties, stored RBC may be unable to maintain
adequate blood flow in capillaries and deliver oxygen
as effectively as their fresh counterparts. If transfused,
stored RBC may be unable to improve perfusion of
the microvascular networks and oxygenation of tissues
immediately after transfusion, and this will reduce the
clinical efficacy of RBC transfusion10,107,108.
Mechanisms of oxidative damage
incurred by stored red blood cells
Oxidative damage – lipid and protein oxidation /
peroxidation and cross-linking caused by reactive
oxygen species, such as hydroxyl, peroxy and alkoxy
radicals – is one of the major factors contributing to
the development of storage lesions. RBC contain a
highly reactive mixture of iron (in Hb) and oxygen
(dissolved in the cytosol and bound to Hb) at very
high concentrations. Iron atoms in Hb must be
maintained in a ferrous state in order to reversibly
bind O2. In vivo, ferrous iron in Hb is protected from
oxidation within RBC, but when the cells are removed
from the body, and stored under refrigerated
conditions, the mechanisms protecting the RBC lose
their efficiency and Hb becomes vulnerable to
oxidation.
Haemoglobin oxidation
and the oxidative damage pathway
Haemoglobin and the products of its denaturation
play a central role in the development of oxidative
damage to stored RBC by serving as catalysts of this
process.  Although the importance of denatured Hb
in the context of oxidative damage during refrigerated
storage was raised back in 1989 by Wolfe109, relatively
few studies that address this issue directly have been
reported since. The involvement of Hb in the
development of storage lesions has been reviewed
recently110.
Haemoglobin contains four ferrous ions, one in
each of its four subunits coordinated in the porphyrin
ring. To fulfil its main physiological function, each
deoxyHb molecule binds four molecules of O2
reversibly, without exchanging electrons (Figure 1A).
RBC maintain a highly reducing environment in their
cytosol to preserve iron in its ferrous form and use
enzymes efficiently to reverse Hb oxidation.
A small fraction of oxyHb spontaneously auto-
oxidizes to form ferric methaemoglobin (metHb) and
a superoxide anion. In circulation, ferric metHb is
reduced back to ferrous Hb by NADH-linked
cytochrome b5 reductase. In refrigerated storage,
however, this reaction is retarded while the formation
of metHb is enhanced for stored RBC with partially
oxygenated Hb (Figure 1B). Once formed, metHb is
inherently unstable; it denatures readily first to
reversible hemichromes, then to irreversible
hemichromes, and finally to globin and free haem
(haemin; Figure 1C).  The stability of metHb may be
further compromised at storage temperatures similar
to a lower thermodynamic stability of met-myoglobin
at 4°C (cold denaturation)111.
Ferric iron in hemichromes, free haem and
molecular iron released from haem can all function
as a Fenton reagent in the Harber-Weiss cycle fed by
H2O2 to generate highly reactive hydroxyl radicals
(Figure 1D). Hydroxyl radicals (•OH) attack proteins
and (in the presence of oxygen) initiate a lipid
peroxidation cycle in RBC membrane (Figure 1E).
Polyunsaturated fatty acids in lipids are attacked by
•OH to form lipid radicals, which then form lipid
hydroperoxyl radicals with oxygen, which in turn
attack polyunsaturated lipid to complete the cycle.
This cycle continues in presence of oxygen until two
radicals react to terminate the reaction, resulting in
cross-linked lipids112.
Haemoglobin auto-oxidation
under conditions of partial oxygen depletion
H2O2 is a substrate for the Harber-Weiss reaction
that produces hydroxyl radicals and itself is a product
of superoxide dismutase reacting on superoxide anion,
a byproduct of Hb auto-oxidation (Figure 1B and D).
Because metHb forms when oxyHb auto-oxidizes, the
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Figure 1 - Haemoglobin and pathways of oxidative damage in RBC.
Panel A: Normal function of Hb-reversible binding of O2 to reduced (ferrous) haems in Hb. Panel B: Auto-oxidation of
oxyHb to methaemoglobin (metHb; ferric) with production of superoxide anion.  In a steady state, 1-2% of Hb exists as
metHb in the circulation; metHb is readily reduced back to ferrous Hb by NADH-linked cytochrome b5 metHb reductase.
Panel C: Denaturation of metHb.  MetHb denatures first to ‘reversible hemichromes’, in which conformational distortions
are minor and can still be reversed.  Reversible hemichromes further denature to ‘irreversible hemichromes’, which
subsequently dissociate to globins and the haem moiety. Panel D:  The Harber-Weiss reaction produces hydroxyl radicals,
•OH. Superoxide anions generated in the production of metHb are converted into H2O2 by superoxide dismutase. Hydroxyl
radicals are produced with H2O2 and ferrous iron from denatured metHb products functioning as Fenton reagents. Ferric
iron is reduced by superoxide anions.  Hydroxyl radicals oxidize and cross-link RBC proteins in their vicinity. Panel E:
Lipid peroxidation cycle. Hydroxyl radicals in the membrane attack unsaturated lipids to form lipid radicals, then combine
with molecular oxygen to form lipid peroxyl radicals, which in turn attack unsaturated lipid to complete the cycle.
concentration of dissolved O2 is a critical factor in
determining the rate of metHb formation.
Balagopalakrishna et al. reported that the rate of
metHb formation and superoxide production reached
a maximum when Hb was only partially occupied by
O2 in a hypoxic state (SO2 ~60%) rather than fully
oxygenated at a high pO2113. In this context, the current
practice of collecting and processing venous blood,
and placing it in storage at a starting SO2 of nearly
60% and then allowing the blood to oxygenate further
to nearly 100% during the 6 weeks of storage as
oxygen slowly diffuses through the plastic film of the
storage bag, likely exacerbates the oxidative damage
experienced by stored RBC.
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The effect of oxidative damage
on stored red blood cells
Obtaining unequivocal direct evidence of oxidative
damage to RBC during refrigerated storage has been
difficult prior to the application of highly sensitive
and specific proteomic techniques114,115. For example,
a simple measurement of metHb levels may not
accurately reflect the rate of metHb formation or the
extent of oxidative reactions during storage due to
the transient nature of unstable metHb. A small
fraction of RBC that were nearly senescent at the time
of blood collection and damaged RBC may cause high
readings of free Hb, haem and other by-products of
oxidation. Thus, most available evidence regarding
the mechanisms of Hb-mediated oxidative damage
and their impact on the physiological function of RBC
were obtained from in vitro experiments exposing
RBC to oxidative stress104,116-121 or from studying RBC
from patients with various haemoglobinopathies (such
as sickle cell disease or thalassaemia)122-125 and other
conditions (such as glucose-6-phosphate
dehydrogenase deficiency or myelodysplastic
syndrome)126,127.
During conventional (aerobic) storage, a
progressive increase in overall protein oxidation has
been observed128-130. D'Amici et al. demonstrated a
significant reduction in the rate of increase in  the
number of spots on a two-dimensional gel of RBC
proteins (an indicator of protein modification and
fragmentation) in the first week of storage for
anaerobically stored RBC relative to those stored
aerobically (conventionally), suggesting a reduced rate
of RBC protein oxidation under anaerobic conditions.
By employing standard proteomic techniques, they
also identified proteins that were modified early and
in an O2-dependent manner, including band 4.2
(prevalent), band 4.1, band 3 and spectrin (minor)114.
Messian et al. observed a loss of oxygen-dependent
metabolic modulation in RBC stored aerobically131.
In addition to these physical and chemical
perturbations, a decrease in glutathione (GSH) levels
and in activity of GSH-dependent glutathione
peroxidase were observed during storage132.
After Hb auto-oxidizes to metHb, it denatures to
hemichromes, which then precipitate onto the lipids
and the cytoskeleton of  RBC membrane. Subsequent
clustering of band 3 caused by this precipitation allows
the immune system of the recipient to recognise and
cull the transfused RBC from the circulation109.
Precipitated hemichromes also disrupt the interactions
between other proteins of the cytoskeleton (spectrin,
actin and band 4.1)109,133. Hemichromes undergo
further denaturation into haemin, globin and free
molecular iron, all of which readily partition into lipid
bilayers. Free haem is a potent haemolytic agent; it
causes RBC haemolysis by collapsing the cationic
gradient134. Haemin and free molecular iron can also
function as Fenton reagents to generate hydroxyl
radicals, which in turn initiate lipid and protein
peroxidation reactions. Peroxidation of the lipids and
proteins of the RBC membrane results in an increased
susceptibility to cation leaks, elevated phosphatidyl
serine exposure, vesiculation and haemolysis. All of
these changes prime RBC for suicidal cell death
(eryptosis) in the circulation135. Excessive vesiculation
due to oxidative damage leads to a disproportionately
higher loss of membrane area than volume; as the
surface area-to-volume ratio decreases, stored RBC
change shape, ultimately approaching a sphere.  This
change in the surface area-to-volume ratio and the
cross-linking of membrane lipid and proteins of the
cytoskeleton caused by the hydroxyl radicals
contribute to the significant reduction of deformability
of stored RBC93,96,109,118,120,124,125.
Prevention of oxidative damage
during red blood cell storage
Previous attempts to reduce oxidative damage
There are two possible approaches to reducing the
rate of oxidative damage during RBC storage: adding
anti-oxidants to the storage solution, or removing
oxidants from RBC suspension.
Reducing oxidative damage by addition of anti-
oxidants or precursor molecules to augment the RBC's
own anti-oxidative mechanisms is an attractive
approach that has shown its effectiveness in improving
RBC biochemical parameters measured in
vitro116,136,137. For example, Dumaswala et al. proposed
supplementing additive storage solution with GSH
precursor amino acids (glutamine, glycine and N-
acetyl-L-cysteine) to prevent the gradual decline in
GSH levels during storage, and to maintain a reducing
environment in RBC cytosol. Although an
enhancement in GSH levels and various other
biochemical parameters was observed, the actual
impact of these changes on in vivo recoveries is not
Blood Transfus 2010;8:220-36  DOI 10.2450/2010.0022-10
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yet known138. Any modification of currently used
storage solutions (especially by adding new
ingredients), however, will require exhaustive studies
of safety before gaining an approval for routine use
from regulatory authorities (such as the US Food and
Drug Administration).
An alternative approach to reducing oxidative
damage is to remove O2 from RBC suspensions in
the beginning and throughout storage – thus shutting
down the haemoglobin denaturation pathway and
arresting all oxidative reactions fuelled by O2
(Figure 1). This approach is feasible due to a unique
feature of RBC: unlike normal eukaryotic cells, RBC
rely solely on anaerobic glycolysis (rather than
oxidative phosphorylation carried out by
mitochondria) for their energy metabolism.
Högman's group reported on the  in vitro
characterisation of RBC stored in a canister filled with
N2 to prevent oxygenation of venous blood during 6
weeks of storage139. In that study, RBC were prepared
for storage conventionally (i.e., not de-oxygenated).
By preventing oxygenation of Hb through the wall of
the polyvinyl chloride blood bag (which happens
slowly during conventional storage), and allowing
gradual equilibration of O2 and N2 in the canister, they
observed a decrease of SO2 from ~60% to 32% over
the 6-week period, compared to an increase in SO2 to
nearly 100% for RBC stored conventionally139. These
authors reported a higher ATP level and an increased
RBC deformability, although no in vivo data were
collected. However, since the rate of Hb auto-
oxidation reaches a maximum at an SO2 of around
60%113, it is doubtful that the procedure used by
Högman et al. was an optimal approach to reducing
oxidative damage.
Red blood cell storage
under strictly anaerobic conditions
Apart from our own work48-51, there has been
neither systematic nor in vivo studies reported in the
literature on the storage of RBC in which O2 is stripped
from Hb at the beginning of storage and maintained
at that level (e.g., in an anaerobic canister) throughout
the whole duration of storage.
In our efforts to reduce oxidative damage during
RBC storage, we attempted to reduce SO2 at the
beginning of storage to a level as low as practical,
and then maintained (and further reduced) SO2 during
the entire storage duration.  This was accomplished
by first equilibrating the RBC suspension with Ar gas
repeatedly over a period of 1 hour prior to refrigerated
storage (SO2 was reduced to less than 3.6%), then
storing RBC in a standard blood bag inside an
anaerobic canister filled with Ar and H2 (9:1) with a
palladium catalyst (to further deplete O2 during the 6
to 9 weeks of storage)51.
Impact of oxygen removal
on the development of oxidative damage
Reducing SO2 to a very low level early in storage
may alleviate the extent of oxidative damage being
accumulated by RBC via the following possible
mechanisms:
i) reducing the concentration of oxyHb and thus
reducing the concentration of metHb produced by
auto-oxidation of oxyHb (Figure 1, Panel A-B);
ii) preventing disruption of the membrane and
cytoskeleton caused by hemichromes, haemin and
globin (the products of metHb denaturation) and
thus reducing haemolysis and eryptosis (Panel C);
iii) preventing production of free haem and iron
(Fenton reagents in the Harber-Weiss reaction for
hydroxyl radical production);
iv) reducing production of superoxide anion
(superoxide anion feeds the Harber-Weiss reaction
in two ways: as a substrate to reduce ferric iron
and as a precursor to H2O2, Panel D);
v) reducing production of hydroxyl radicals and
subsequent cross-linking of cytoskeletal proteins
to prevent reduction in deformability (Panel D);
vi) curtailing lipid peroxidation reactions (at SO2=4%,
free oxygen concentration is reduced to less than
1% of air-saturated blood at 4°C, Panel E) to reduce
haemolysis and eryptosis.
Metabolic consequences of oxygen removal
An overwhelming fraction of protein contained in
the cytosol of RBC is haemoglobin. Consequently,
the biochemistry of Hb determines the rates of
oxidative reactions and influences the energy
metabolism of RBC, and thus Hb plays a primary role
in the development of metabolic storage lesions.
Hb is a tetrameric protein that may exist in two
conformations with different affinities for O2– the high
affinity R-state (oxygenated) and the low affinity T-
state (deoxygenated). In addition to O2, Hb binds other
ligands – heterotropic effectors – with affinities that
Oxidative damage prevention of blood:anaerobic storage
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depend on its conformation. Hb exerts control of
metabolic reactions by modulating the concentration
of free ligands through its own conformational
transition.  H+, 2,3-DPG and (to a lesser extent) ATP
are the heterotropic effectors of Hb, which directly
affect the production of ATP by the glycolytic pathway
and of 2,3-DPG by the Rapoport-Luebering shunt.
As illustrated in Figure 2A, ATP and 2,3-DPG function
as end-product inhibitors of phosphofructokinase
(PFK) and pyruvate kinase (PK). PFK is also inhibited
by low pH resulting from lactate production. In
addition, Hb modulates the activity of glycolytic
enzymes, namely PFK, glyceraldehyde-3-phosphate
dehydrogenase, aldolase and lactate dehydrogenase
by oxygen-dependent metabolic modulation140. When
these enzymes bind to the cytoplasmic binding domain
of band 3, their activities are inhibited141. DeoxyHb
(Hb in T-state) competitively binds the same binding
domain of band 3, thus releasing PFK and other
enzymes, disinhibiting their activity and increasing
the glycolytic flux.
When O2 dissociates from oxyHb, the following
events take place: (i) Hb conformation is forced from
the R- to T-state; (ii) Hb binds 2,3-DPG at a near 1:1
stoichiometric ratio because the affinity of Hb for 2,3-
DPG is higher in the T-state; (iii) deoxyHb binds H+
(Bohr proton); and (iv) deoxyHb preferentially binds
to the cytoplasmic binding domain of band 3, thereby
releasing PFK and other glycolytic enzymes (Figure
2B). The increased affinity of deoxyHb to 2,3-DPG
and ATP reduces their cytosolic concentrations thus
removing inhibition from PFK and PK; uptake of Bohr
proton increases cytosolic pH, up-regulating PFK even
further. The binding of deoxyHb to the binding
domain of band 3 and the consequent displacement
of PFK and other glycolytic enzymes also up-regulates
glycolytic activity131,140. These changes result in an
increase in glycolytic flux and activity of 1,3-DPG
mutase as indicated by the elevated levels of lactate
and ATP (Table I) as well as 2,3-DPG levels in the
first two weeks of storage50.
Figure 2 -Oxygenation state of haemoglobin and RBC energy metabolism.
Panel A:  Hb in oxygenated state.  Bars at PFK, PK and 1,3-DPG mutase steps indicate end product inhibitions by ATP, 2,3-DPG and low pH.
The large arrow indicates binding of PFK and other glycolytic enzymes to the cytosolic binding domain of band 3 (thus reducing their
enzymatic activity).  Panel B:  RBC in anaerobic conditions.  Hb in T-state binds 2,3-DPG, H+ and ATP (to a limited extent) thereby releasing
the inhibitory steps (grey bars).  DeoxyHb has higher affinity toward the cytoplasmic binding domain of band 3; upon binding to band 3,
deoxyHb displaces and thus activates PFK and other metabolic enzymes.  Panel C:  When CO is used in place of Ar to deplete O2 in gas
exchange, CO binds (nearly) irreversibly to Hb, fixing it in R-state and releasing Hb from the binding domain of band 3. This enables PFK and
other enzymes to bind to band 3, which effectively removes them from glycolytic reactions.  Due to a lower affinity of R-state, Hb releases
ATP, H+ and 2,3-DPG, elevating their free cytosolic concentrations, and inhibiting key enzymes resulting in reduction of glycolytic flux.
Blood Transfus 2010;8:220-36  DOI 10.2450/2010.0022-10
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Clinical studies with anaerobically stored red
blood cells
In the past 12 years, we have conducted five clinical
studies with anaerobically stored RBC to assess the
utility of anaerobic storage using an in vivo metric of
quality of stored RBC – autologous 24-hour recovery
of 51Cr-labelled RBC in human subjects. Studies III-V
(described below) were designed as dual-arm trials in
which RBC from the same subject were stored
following conventional aerobic procedures (control)
and under anaerobic conditions (test). We tested several
experimental additive solutions as well as AS-3 (Pall
Corp., Port Washington, NY, USA) in combination with
the anaerobic conditions in these studies, the initial goal
of which was to achieve the longest possible storage
shelf-life of RBC units (Table II).
In all five studies, SO2 of Hb was reduced to below
4% by an experimental gas exchange protocol51.  The
gas exchange was conducted by transferring packed
RBC into 1 L transfer bags, filling the bags sterilely
with Ar, gently agitating the bags for 10 min, and
finally expressing Ar/O2. After repeating the gas
exchange six times, the RBC suspension was
transferred to the original polyvinyl chloride storage
bag, and placed in an anaerobic canister filled with
90% Ar /10% H2; a palladium catalyst was included
in the canister to prevent O2 re-entry and to further
deplete O2 during storage. The results of these studies
are summarised below.
Metabolic and biochemical parameters
Under conventional (aerobic) storage conditions,
ATP concentration peaks at 10-20% above starting
level around 3 weeks of storage and then gradually
declines. Under anaerobic conditions, depending on
the additive used, ATP peaks at higher levels (50-70%
above the initial concentration), and this phase of ATP
boost is sustained for a longer period (5-7 weeks).
After the level of ATP reaches its peak, the rate of
decline is similar for aerobic and anaerobic storage.
Because ATP peaks later and at a higher level,
however, ATP levels of anaerobic RBCs remain above
the fresh level even after 6 weeks of storage.
In anaerobic storage, 2,3-DPG levels are sustained
significantly longer than in conventional storage: 2,3-
DPG increases to over 100% of the initial level within
the first week and then declines to below the initial
concentration only in week 3. The levels of haemolysis
are similar for the first 6 weeks for both types of
storage, but then diverge significantly beyond 8 weeks
when the rate of haemolysis of aerobically stored RBC
begins to increase. Phosphatidyl serine exposure
increases slowly in the first 6 weeks in both aerobic
and anaerobic conditions; at week 6, aerobic RBC
show an exponential increase in phosphatidyl serine
exposure, while for anaerobic RBC the rate of increase
is more gradual and the exponential phase is delayed
for about 3 weeks.
Prior to initiating study IV, we had examined the
effect of pH of the experimental additive solutions on
in vitro parameters (ATP, 2,3DPG and haemolysis)
and found that good results could be obtained by
acidifying an alkaline experimental additive solution
(EAS6146).  In study IV, in addition to using this
adjusted additive with low pH (OFAS3), we added
metabolic precursors (PIPA: phosphate, inosine,
pyruvate, adenine; Rejuvesol, EnCyte System Inc.,
Braintree, MA, USA) to the storage solution to ensure
an adequate supply of nutrients during a storage period
of 12 weeks and beyond.  In this study, we
demonstrated that50:
i) PIPA supplementation at 4°C (as opposed to
incubation at 37°C) boosted ATP and 2,3-DPG
levels within 1 week.
Table II - Additive solutions used in clinical studies on
anaerobic storage
Study
(mM) I II III IV*, V
OFAS1 AS-3 EAS61 OFAS3
Adenine 2 2.2 2 2
Dextrose 110 61 110 110
Mannitol 65 55 55
NaCl  70 26 26
Na citrate 20 20  
Citric acid  2  
Na2HPO4  12 12
NaH2PO4 20 20   
pH 7.2 5.8 8.3 6.5
mL added 250 200 200 200
* In study IV, PIPA supplement was also added at weeks 7 and 11 of
storage for the test (anaerobic) units.  Rejuvesol (0.55 g sodium pyruvate,
1.34 g inosine, 0.034 g adenine, 0.5 g dibasic sodium phosphate
monohydrate, pH 6.7-7.4; 50mL per addition, EnCyte Systems, MA, USA).
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ii) PIPA addition reversed the scrambling of
membrane lipids by allowing the translocation of
previously exposed phosphatidyl serine back to
the inner leaflet of the membrane.
iii) Addition of PIPA to the blood bag twice during
anaerobic storage maintained ATP and 2,3-DPG
at the level of fresh RBC and suppressed
phosphatidyl serine exposure for more than 17
weeks.
24-hour recovery of red blood cells stored
anaerobically
Study I
Our first study utilised a hypotonic experimental
additive solution (250 mL, 125 mOsm/L effective,
Table II.  In this small, pilot trial, 24-hour recovery
of more than 75% was recorded for RBC stored in
this additive solution anaerobically for 8 (n=6) and 9
weeks (n=4). This study provided the first evidence
of the utility of anaerobic storage48.
Study II
Our second study examined an existing additive
solution, AS-3, in a serial protocol in which one unit
collected from a donor was tested for 24-hour recovery
three times consecutively, at weeks 8, 9 and 10 of
anaerobic storage. A double volume of AS-3 additive
was used to prevent the possible exhaustion of glucose
under the conditions of glycolytic flux elevated for a
prolonged period of time in extended storage. The
results indicated that anaerobic storage is compatible
with the existing additive solution for up to 9 weeks51.
Study III
Neither additive solutions currently in use nor the
experimental additives that demonstrate extended
storage times43-46,142 specifically aim to reduce
oxidative damage. We hypothesised that anaerobic
storage conditions will be synergistic with advanced
additives to further prolong the shelf life of units by
reducing the rate of development of storage lesions
due to oxidative damage in addition to the direct effect
of anaerobic conditions on the metabolic status of
RBC (Figure 2). We tested this hypothesis in study
III for an advanced experimental additive solution
with high pH (8.4) which showed success in a 9-week
storage under conventional aerobic conditions46.
To avoid the large subject-to-subject variability
inherent in studies with a small number of subjects,
this study was also designed as a dual-arm trial in
which RBC from the same subject were collected on
two separate occasions, stored under aerobic and
anaerobic conditions in a random order, and tested to
isolate the effect from anaerobic storage conditions
on storage duration.
Unexpectedly, our results showed that no further
gain was achieved when anaerobic storage was
combined with the alkaline additive solution. We also
found that subjects whose RBC stored better in one
arm had comparable results in the other arm of this
study. Two plausible explanations for the observed
lack of synergy are that: (i) the cytosol of RBCs
became too basic for optimal function because of over-
alkalinisation produced by the gas exchange (since
both O2 as well as CO2 are removed in this process)
and due to the activity of carbonic anhydrase; and (ii)
factors other than oxidative damage (e.g., metabolic
deficiency) limited the post-transfusion survival of the
RBC51.
Study IV
Based on in vitro experiments completed after
study III, we conducted another dual-arm study, this
time using an acidic experimental additive (OFAS3).
In the control arm, RBC were stored with OFAS3
additive in aerobic conditions. In the test arm, RBC
were stored anaerobically with OFAS3, and PIPA
supplementation was added (without warming the
units) at weeks 7 and 11 of storage. We measured 24-
hour in vivo recovery of the RBC in both the test and
control arms after 10 weeks of storage. Units in the
test arm were re-examined after 12 weeks and,
depending on the observed recovery, again at week
14 or 16 of storage (Table I)*. For the test arm
(anaerobic storage), an acceptable recovery rate was
measured at week 12 for all units**, and two units with
good recovery at week 14 also showed adequate
recovery at week 16.
Oxidative damage prevention of blood:anaerobic storage
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* Two were dropped from the study after 10 weeks because
of lower than 75% recovery for the Test arm.
** Out of 6 subjects with 75% recovery or more at 10 weeks
of storage, 4 were tested at week 12 and week 14; 2
subjects with highest values at week 10 were tested at
week 14 and week 16 (both subjects scored higher than
75% at week 14).
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This study demonstrated that when anaerobic
storage was combined with supplements of PIPA,
RBC stored for 12 weeks showed acceptable survival
in vivo and maintained high 2,3-DPG levels such that
full oxygen delivery capacity would be available
immediately after transfusion (and not only 8-24 hours
later when transfused RBC stored conventionally
recover their function in vivo)50.
Study V
In this dual-arm, 8-subject study we stored
leucoreduced RBC anaerobically in OFAS3 additive
solution (test arm) and aerobically in AS-3 additive
solution (control arm). We measured the 24-hour
recovery at 6 weeks (test and control) and at 9 weeks
(test only); we also determined the rate of long-term
survival of transfused RBC after each of these three
infusions.
The results of this study demonstrated that 6-week
control and 9-week test units were equivalent in terms
of 24-hour recovery, morphology scores, and ATP
levels. Two subjects with relatively high haemolysis
after 6 weeks (control) showed greater than 1%
haemolysis after 9 weeks (test). The long-term survival
rate was indistinguishable between all three infusions
suggesting that for those RBC that survive the initial
stress related to infusion and/or scrutiny by the
reticuloendothelial system of the recipient, a normal
life-span can be expected regardless of the storage
methods used49.
Summary of in vivo studies
The following conclusions can be drawn from the
results of these five clinical studies:
- anaerobic conditions could extend the storage time
by more than 50% while maintaining acceptable
viability of stored RBC in vivo;
- anaerobic storage conditions in combination with
an acidic additive solution had a synergistic
beneficial effect on stored RBC; a combination with
an alkaline additive conferred no additional benefit;
- ATP and 2,3-DPG could be maintained at high
levels throughout the extended duration of
anaerobic storage by adding PIPA supplement
twice during storage without warming the units;
- maintaining high ATP levels throughout storage
did not guarantee high 24-hour recovery post-
transfusion;
- the level of phosphatidyl serine exposure at the
time of re-infusion did not correlate with the rate
of RBC survival in vivo;
- the significant reduction in oxidative damage
combined with metabolite precursor supplements
could not extend storage beyond 12 weeks for most
units. Therefore, other factors – such as
accumulation of toxic products or cold
denaturation of RBC proteins – may be damaging
RBC in storage and reducing their viability in vivo;
- no difference was observed in the long-term
survival rates between RBC stored in aerobic and
anaerobic conditions once the cells survived the
first 24 hours in vivo.
Effects of carbon dioxide depletion
during gas exchange
The process of gas exchange used in these studies
was effective in removing O2 as well as dissolved
carbon dioxide (CO2). Depletion of CO2 may have
caused alkalosis in RBC cytosol, which may have
contributed to the observed increase in glycolytic flux
yielding high levels of ATP51,143. To rule out this
possibility, we used CO (instead of Ar) for gas
exchange in order to force Hb into the R-state (COHb),
while still alkalizing RBC by CO2 removal. In these
experiments, gas exchange with CO depleted O2 and
CO2 (as with Ar in all other anaerobic experiments),
but the ATP levels were suppressed (instead of
enhanced) relative to those of the aerobic controls51.
This observation can be explained by CO binding
to Hb: because the affinity of Hb to CO is 200 times
higher than for O2, Hb was locked into R-state and
thus released 2,3-DPG into the cytosol. This process
also freed the binding domain of band 3 for PFK and
other glycolytic enzymes to bind (Figure 2C). Since
RBC contain neither mitochondria nor metabolic
enzymes to be inhibited by CO, the reduced ATP levels
can only be attributed to a reduced glycolytic flux144.
On the other hand, the Hb-CO complex is extremely
stable and once formed it prevents any auto-oxidation
from taking place and causing oxidative damage.
These results showed that even if cytosolic
alkalinisation caused by CO2 removal played a role
in elevating the level of ATP, the contribution was
insignificant in comparison to the effect on glycolytic
flux from the conformational transition of Hb.
Blood Transfus 2010;8:220-36  DOI 10.2450/2010.0022-10
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Practical implementation of anaerobic storage
In all clinical studies described above, the initial
depletion of O2 was carried out manually using an
experimental protocol of gas equilibration in a large
transfer bag. Deoxygenated RBC were then stored in
an anaerobic canister to prevent re-oxygenation. We
are now designing and fabricating a prototype blood
collection/storage system to replace this manual
experimental protocol.  Our goal is to make this new
anaerobic storage system: (i) self-contained; (ii)
disposable; (iii) inexpensive; (iv) easy to gain approval
under current blood banking regulations; (v) require
no or minimal additional infrastructure; and (vi)
require minimal departure from the current operational
modality of blood banks.
The prototype system consists of a device for the
initial O2 depletion and a multi-layered anaerobic
storage bag impermeable to O2. Initially, the system
will be made compatible with packed RBC units
prepared by the currently available blood collection
sets. Anaerobic RBC will be prepared by sterilely
connecting a unit of packed leucoreduced RBC to the
O2-depletion device, passing the RBC through the
device to deplete O2, and collecting the deoxygenated
RBC into the anaerobic storage bag. Future versions
will include a complete blood collection set
incorporating the anaerobic system with additive
solution, blood component bags and a leucoreduction
filter. The O2-depletion device will resemble a dialysis
cartridge commonly seen in renal dialysis instruments.
In place of the flowing dialysate, O2 sorbent granules
will be packed around the hollow fibres to scavenge
O2 from the suspension of RBC passing inside the
fibres. Deoxygenated RBC will be placed in a
conventional polyvinyl chloride blood storage bag –
this bag will be either laminated on both sides to make
it impermeable to O2, or will be contained within an
O2-barrier bag containing a sachet with an O2 sorbent
to compensate for possible leakage of O2 and to further
deplete O2 during storage.
Utility of anaerobic storage
The use of RBC units with a higher proportion of
viable cells at the time of transfusion would benefit
chronically transfused patients directly: transfusing
fewer non-viable RBC reduces iron overload and may
increase the clinical efficacy of transfusion.
The number of RBC units discarded due to
outdating in the developed countries is low. In the
US, outdate rates are usually <2%, and most of this is
due to A+ and AB blood types. Furthermore, in 2007,
the average age of transfused units was 19.5 days in
the US nationally145, 21±11 days for patients in
Intensive Care Units7 and 20±11 days for trauma
patients, only 18% of whom received RBC units
stored for longer than 40 days146. Thus, there is little
urgency to extend the shelf-life of RBC units in
general transfusion therapy (with a possible exception
of the military setting147). There is little doubt,
however, that RBC are damaged during refrigerated
storage and that this damage increases progressively
with the duration of storage. There is a growing (yet
controversial) concern regarding the negative
consequences of transfusing "old" RBC16. Strategies
to reduce the rate of development of storage lesions
are particularly timely and should warrant rigorous
pursuit. Extending the shelf-life of stored RBC is one
way of reaching this goal. The use of RBCs with a
shelf life extended by 50% under current normal
practices would effectively amount to the use of
relatively "fresher" blood even though the "nominal
age" would be the same.
Currently, we expect anaerobic storage to benefit
cardiac surgery and critical care patients as numerous
recent reports have suggested an association between
the age of transfused units and poor clinical outcomes
in these groups of patients (for a recent comprehensive
review see Lelubre et al.16). More general conclusions
must await results of two ongoing large clinical trials
of the efficacy of RBC transfusion*** aimed at
determining a correlation between the age of RBC
units and patients' outcomes. The potential utility of
anaerobically stored RBC would not be limited to
specific groups of patients and could be made
universally available if an inexpensive anaerobic
storage system could be developed and incorporated
into the current blood banking operation without
causing a major disruption to normal procedures.
Conclusions
In the past, oxidative damage to RBC has been
studied extensively in the context of patients suffering
Oxidative damage prevention of blood:anaerobic storage
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***Red Cell Storage Duration and Outcomes in Cardiac
Surgery, n=2,800; and Red Cell Storage Duration Study
(RECESS), n=1,612 (http//:clinicaltrials.gov).
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from hereditary haemoglobinopathies. The
mechanisms and the impact of oxidative reactions on
the physiological function of RBC are now well
understood. Because of its abundance and high
reactivity, haemoglobin plays a central role in
promoting the oxidation in RBC with oxygen (present
at a relatively high concentration in the cytosol of the
cell) acting as a fuel in this process. Despite multiple
reports implicating or hypothesising oxidative damage
mediated by denatured Hb as the major driving force
in the development of storage lesions109,148, until
recently, little effort has been focused on reducing
oxidative damage directly. Moreover, a mere handful
of reports exists unequivocally demonstrating
evidence of specific oxidative damage in the early
stages of RBC storage.
An attractive way to reduce oxidative damage
during refrigerated storage is to eliminate for the entire
duration of storage a critical substrate of oxidative
reactions – oxygen. In a series of pilot clinical studies,
we tested this hypothesis by stripping oxygen away
from haemoglobin at the onset of storage and
maintaining the anaerobic conditions throughout the
storage. Our 24-hour recovery data suggest that
anaerobic conditions combined with existing additive
solutions can reduce the rate of development of storage
lesions and extend the refrigerated storage of RBC
by 50% or more. On the other hand, anaerobic storage
reduces the rate of storage lesion development during
storage and, therefore, has the potential to improve
the functional quality of RBC stored for any given
duration. In addition to these 24-hour in vivo recovery
data, a recent comprehensive proteomic study of the
early development of oxidative damage to membrane
proteins and the cytoskeleton of RBC showed a
significant reduction of oxidative damage in anaerobic
conditions114.
At this time, there are no definitive data available
to correlate the extent and/or type of oxidative damage
and the viability and efficacy of stored RBC in vivo.
It appears prudent, however, to look for strategies for
combating the development of oxidative damage
during storage. In pursuing this goal, storing RBC in
anaerobic conditions offers an attractive alternative
to the addition of anti-oxidant chemicals to the additive
storage solution primarily because anaerobic storage
completely avoids the safety concerns associated with
infusing these chemicals into the recipient during
transfusion. A larger clinical study examining the
correlations between the extent and nature of oxidative
damage and the 24-hour in vivo recovery of stored
RBC is currently underway. If a causal relationship
can be established, RBC preserved in a user-friendly,
self-contained anaerobic blood collection/storage
system will provide more viable, "fresher" RBC to
all patients receiving transfusions.
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